PHYREXIA: ALL WILL BE ONE

Jawbone Duelist

Jawbone Duelist

顎骨の決闘者


クリーチャー — ファイレクシアン・兵士


二段攻撃 毒性1(このクリーチャーから戦闘ダメージを受けたプレイヤーは追加で毒カウンター1個を得る。)


「私の歯牙コレクションにはまだ空きがあるぞ。次は誰だ?」


1 / 1


Illustrated by Nino Vecia

· Phyrexia: All Will Be One (ONE)


Jawbone Duelist


#18 · Uncommon · Japanese · Nonfoil/Foil


Legal Formats

Standard
Pioneer
Modern
Legacy
Vintage
Commander
Oathbreaker
Alchemy
Explorer
Historic
Timeless
Brawl
Pauper
Penny

Variants

Under Construction

Prints


Rulings


2023-02-04 : A player with ten or more poison counters loses the game. This is a state-based action and doesn't use the stack. In other words, it happens immediately and players can't respond to it, just like a player losing the game due to having 0 or less life.

2023-02-04 : Any other effects of that damage, such as life gain from lifelink, still apply.

2023-02-04 : Conversely, replacement effects that apply to the number of counters put on a player can modify the counters placed this way. For example, Vorinclex, Monstrous Raider's last two abilities can apply to counters placed this way.

2023-02-04 : Damage dealt by a creature with toxic grants the same number of counters regardless of how much damage is dealt. Notably, if a replacement effect modifies the damage in some way (such as that of Gratuitous Violence), the number of counters given remains unchanged.

2023-02-04 : If a creature with toxic deals combat damage to a creature or planeswalker, or if it deals noncombat damage, toxic has no effect and no player gets poison counters.

2023-02-04 : Multiple instances of toxic are cumulative. For example, if a creature has toxic 2 and gains toxic 1 due to another effect, combat damage that creature deals to a player will cause that player to get 3 poison counters.

2023-02-04 : Toxic doesn't change the amount of combat damage a creature deals. For example, if a 2/2 creature with toxic 1 deals combat damage to a player, that creature will deal 2 damage. The results of that damage are the player loses 2 life and gets a poison counter.

Comments

Under Construction